Docusign Analysts Raise Their Forecasts After Better-Than-Expected Q2 Earnings

Benzinga Earnings
09/04

Docusign Inc (NASDAQ:DOCU) on Thursday posted upbeat financial results for the second quarter of fiscal 2027 and raised its fiscal 2027 revenue outlook.

Docusign posted second-quarter revenue of $875.75 million, beating the consensus estimate of $857.43 million, according to Benzinga Pro. The agreement management company reported adjusted earnings of $1.16 per share for the quarter, beating estimates of $1.09 per share.

Docusign expects third-quarter revenue to be in the range of $886 million to $890 million versus estimates of $888.56 million. The company also raised its fiscal 2027 revenue outlook to $3.499 billion to $3.507 billion, up from $3.49 billion to $3.502 billion, versus estimates of $3.497 billion.

“Docusign is raising its outlook as AI accelerates momentum across the business,” said Allan Thygesen, CEO of Docusign.  “We said IAM would be the agreement system of action, and this quarter we delivered. Our AI agents are now securely executing contract workflows end-to-end, and the IAM platform also ingested a record volume of agreements.”

Docusign shares gained 2.5% to trade at $67.59 on Friday.

These analysts made changes to their price targets on Docusign following earnings announcement.

  • UBS analyst Karl Keirstead maintained the stock with a Neutral and raised the price target from $54 to $70.
  • RBC Capital analyst Rishi Jaluria maintained the stock with a Sector Perform and boosted the price target from $55 to $70.
  • Wells Fargo analyst Michael Turrin maintained the stock with an Equal-Weight rating and raised the price target from $55 to $60.
  • Baird analyst William Power maintained the stock with a Neutral and raised the price target from $55 to $72.
  • B of A Securities analyst Matt Bullock maintained the stock with an Underperform rating and lifted the price target from $58 to $64.

Considering buying DOCU stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10